Pharma

Pharma·

Lilly’s Foundayo Wins EU Panel Nod — Brussels Bureaucracy Gets a Rare Win

Pharma·

China Tightens Biotech Export Rules — But Leaves the Licensing Door Ajar

Pharma·

City Therapeutics Upsizes $200 Million IPO — RNAi Pipeline Wins Wall Street Bet

Pharma·

FDA Uncovers Black Mold in Chinese Plants Supplying Compounded GLP-1 Drugs

Pharma·

Ebola Spreads to Eighth Congo Province as Young Children Face Heavy Toll

Ebola Spreads to Eighth Congo Province as Young Children Face Heavy Toll
Pharma·

RevMed’s Pancreatic Cancer Drug Wins EU Panel Backing — A Win for Real Medicine Over Bureaucratic Drag

Pharma·

Biocon's Kiran Mazumdar-Shaw Sees AI Shortening Clinical Trials as the Real Prize

INE376G01013INE376G01013
Biocon's Kiran Mazumdar-Shaw Sees AI Shortening Clinical Trials as the Real Prize
Pharma·

AI Drug Discovery Is a Capitalist Win — Bureaucrats Need Not Apply

AI Drug Discovery Is a Capitalist Win — Bureaucrats Need Not Apply
Pharma·

GLP-1 Drugs Cut Schizophrenia Relapses in New US Study

Pharma·

FDA’s Rare-Disease Overhaul: Regulators Finally Notice They’re the Bottleneck

Pharma·

Gene-Edited Mosquitoes: A Market Test Worth Running

Pharma·

Olympus Shares Tank as FDA Warning Letter Exposes Six-Plant Weakness

Olympus Shares Tank as FDA Warning Letter Exposes Six-Plant Weakness
Pharma·

Zealand Pharma Lands $1.2 Billion AI-Powered Obesity Bet With Generate

DK0060257814DK0060257814
Zealand Pharma Lands $1.2 Billion AI-Powered Obesity Bet With Generate
Pharma·

BioNTech's Experimental Cancer Drug Flops in Early Head-and-Neck Trial

US09075V1026US09075V1026
BioNTech's Experimental Cancer Drug Flops in Early Head-and-Neck Trial
Pharma·

J&J Beats on New Drugs, Lifts Guidance — Medical Devices the Drag

US4781601046US4781601046
J&J Beats on New Drugs, Lifts Guidance — Medical Devices the Drag
Pharma·

Bristol Myers' Late-Stage Wins: Two New Drugs Clear the Bar

Pharma·

Russia Plague Death Spotlights Vaccine Gaps and WHO Ineptitude

Pharma·

Bambusa Therapeutics Files for IPO to Finance Eczema Drug Trials

Bambusa Therapeutics Files for IPO to Finance Eczema Drug Trials
Pharma·

Eli Lilly-Backed TRex Bio Grabs $116.7 Million in IPO — Priced at the Bottom, Still a Win

Pharma·

J&J Skips Obesity, Doubles Down on Cancer and AI Drug Discovery

US4781601046US4781601046
J&J Skips Obesity, Doubles Down on Cancer and AI Drug Discovery
Pharma·

Tick-Borne Lyme Disease Surges, Drugmakers Race for Vaccines and Blockers

Pharma·

Weight-Loss Drugs May Ease Joint Pain, But They Are No Free Lunch

Pharma·

India's Supreme Court Targets Pharma Sales Tactics — Another Regulatory Hammer Heads for the Industry

Pharma·

Shanghai Allist Plunges 20% as ArriVent Trial Collapse Kills Global Hopes

Pharma·

Russia's Plague Lab Death: Bureaucratic Fog Over a Dead Worker

Pharma·

Merck Loses Keytruda Franchise Protection as European Courts Block Injectable Version

Pharma·

WHO Blocks Obesity Drugs for Kids Under 10 — Bureaucrats Over Parents Again

Pharma·

Eli Lilly-Backed TRex Bio Files for $133.3 Million IPO

US5324571083US5324571083
Eli Lilly-Backed TRex Bio Files for $133.3 Million IPO
Pharma·

Nobel for Optogenetics Hands Investors a New Biotech Frontier

Pharma·

CSL Bets $1.6 Billion on Kidney and Liver Breakthrough